Fibromuscular dysplasia historical perspective

Jump to navigation Jump to search

Fibromuscular dysplasia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Fibromuscular dysplasia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiorgram

X-ray

CT

MRI

Arteriography

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Management Guidelines

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

ASA/ACCF/AHA Guideline Recommendations

Management of Patients With Fibromuscular Dysplasia of the Extracranial Carotid Arteries

Case Studies

Case #1

Fibromuscular dysplasia historical perspective On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Fibromuscular dysplasia historical perspective

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Fibromuscular dysplasia historical perspective

CDC on Fibromuscular dysplasia historical perspective

Fibromuscular dysplasia historical perspective in the news

Blogs on Fibromuscular dysplasia historical perspective

Directions to Hospitals Treating Fibromuscular dysplasia

Risk calculators and risk factors for Fibromuscular dysplasia historical perspective

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Overview

Historical Perspective

Discovery

  • Fibromuscular dysplasia was first introduced by Leadbetter and Burkland in 1938 in a 5-year-old boy with severe hypertension in a unilateral intra-arteria mass. this American-African boy underwent a unilateral nephrectomy and his hypertension was remedied.[1]
  • Although the first histopathological description of this condition performed by McCormack and coworkers by the report of four cases of “fibromuscular hyperplasia” in 1958.[2]
  • The first conception of these occlusive masses was described as hyperplasia and it lasted about 13 years until the exact pathologic classification of fibromuscular dysplasia was proposed in 1971 by Harrison and McCormack.[3]
  • In 2012, after several months of the release of the French Registry for FMD and European Consensus on the diagnosis and management of FMD, the United States Registry for Fibromuscular Dysplasia (US Registry) reported data from the first 447 patients were enrolled.
  • During past decades and especially in recent years, these efforts and publications have dispelled some aspects of FMD enigma.these are significant efforts to improve our clarification of non-atherosclerotic causes vascular accidents. Nevertheless, FMD remains a medical myth specifically at the genetic and molecular levels. It is hoped that the new researches and studies provide more effective and evidence-based information for diagnosis and treatment of FMD.

References

  1. Leadbetter, W.F.; Burkland, Carl E. (1938). "Hypertension in Unilateral Renal Disease". The Journal of Urology. 39 (5): 611–626. doi:10.1016/S0022-5347(17)71895-2. ISSN 0022-5347.
  2. McCormack LJ, Hazard JB, Poutasse EF. Obstructive lesions of the renal artery associated with remediable hypertension. Am J Pathol 1958;34:582. abstract.
  3. E. G. Jr Harrison & L. J. McCormack (1971). "Pathologic classification of renal arterial disease in renovascular hypertension". Mayo Clinic proceedings. 46 (3): 161–167. PMID 5553126. Unknown parameter |month= ignored (help)

Template:WH Template:WS